Investing.com – The Dow rallied Monday after clawing back early losses as a rally in tech stocks offset a decline in Boeing.
The rose 0.79%. The added 1.47%, while the gained 2.02%.
The Dow reversed its steep losses early Monday, led by a rise in Facebook and Apple as analysts upgraded their outlook on both companies.
Bank of America upgraded its rating on Apple (NASDAQ:) to buy from neutral and raised its price target on the stock to $210 from $180, arguing expectations for a decline in tech giant’s hardware sales are somewhat overly negative. Apple’s share price rose 3.5%.
Facebook (NASDAQ:) closed 1.5% higher after Nomura Instinet upgraded its rating on the social media stock to buy from neutral and raised its price target to $215 from $172.
The firm said its concerns over engagement trends at core Facebook have “eased,” as users were transitioning to the company’s Stories feature faster than it had anticipated.
The broader tech market was also supported by a rally in NVIDIA (NASDAQ:) after the chipmaker agreed to buy Isreal’s Mellanox Technologies (NASDAQ:) for $6.9 billion.
The deal requires Chinese regulatory approval as the country accounted for 24% of Mellanox’s $1.1 billion of revenue in 2018. If the deal is approved, it could pave the way for more deals in the semiconductor industry as companies have held back after China failed to approve Qualcomm (NASDAQ:)’s planned $44 billion purchase of NXP Semiconductors NV (NASDAQ:).
In industrials, Boeing (NYSE:) pared some losses to end the day down 5.3%, after falling more than 11% intraday. General Electric (NYSE:) clawed back some losses from last week.
Boeing came under pressure in early trade after several airlines grounded the company’s new 737 MAX 8 passenger jet following a deadly Ethiopian Airlines crash. It was the second crash in five months involving a Boeing 737 Max 8.
General Electric (NYSE:) rose 3% after analysts at Citigroup delivered an upbeat assessment of the company’s turnaround program.
“(R)ecent actions (including the close of the sale of GE Transportation to Wabtec and the announced agreement to sell GE Healthcare’s BioPharma unit to DHR for $21.4 billion) buy GE some time to execute its turnaround in a deliberate/orderly manner,” Citigroup (NYSE:) said in a note.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.